Genetics of Systemic lupus erythematosus in northern and southern European popul...
Genetics of Systemic lupus erythematosus in northern and southern European populations
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease mediated by autoantibodies, which recognize nuclear and tissue specific antigens.The aetiology of this disease is incompletely determined. However, the risk to...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2012-34435
APLICACION DE ESTRATEGIAS POST-GWAS EN LA IDENTIFICACION DEL...
205K€
Cerrado
SAF2009-11110
IDENTIFICACION DE LAS BASES GENETICAS DE LA ESCLEROSIS SISTE...
263K€
Cerrado
LUPUSCARE
PRECISION CARE IN SYSTEMIC AUTOIMMUNITY AN INTEGRATED MULTI...
2M€
Cerrado
RTI2018-101332-B-I00
DESCIFRANDO LAS BASES GENETICAS DE LA ESCLEROSIS SISTEMICA
351K€
Cerrado
GENTOPHEN
Linking genotype to phenotype for the rheumatoid arthritis s...
45K€
Cerrado
EEBB-I-12-05770
IDENTIFICACION DE LAS BASES GENETICAS DE LA ESCLEROSIS SISTE...
5K€
Cerrado
Información proyecto GENETICS OF SLE
Líder del proyecto
KINGS COLLEGE LONDON
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
173K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease mediated by autoantibodies, which recognize nuclear and tissue specific antigens.The aetiology of this disease is incompletely determined. However, the risk to SLE has a significant genetic component, a conclusion supported by successful genome wide association studies (GWAS) in SLE published since 2008 - all were conducted in US-based cohorts. The variability within the
top hits generated by each GWAS indicates the lack of power of these studies. In order to confidently define the full genetic architecture of SLE a significantly larger study will be required. My host laboratory is leading the effort in a well-powered GWA experiment in 5,500 SLE cases, collected from Northern and Southern Europe. First, high density SNP genotyping will be performed using Illumina Omni-Quad chip. I will participate in the ensuing genetic associations analyses on the data generated. Thereafter, I will make a meta-analysis of these GWAS data with the published GWAS in SLE in northern European populations and then to compare these data with the data of the southern European GWAS. We will seek replication for novel associations in additional samples available through the SLEGEN consortium. Finally I will select one novel locus in which to conduct functional studies that will help to clarify the role of the locus in SLE ethiopathogenesis.